Cigna Corp. Q2 adjusted earnings came in at $6.22 a share, surpassing analysts’ expectations of $5.49 a share ( based on FactSet poll).
The healthcare company's revenue climbed +5.45% year-over-year to $45.48 billion vs. analysts’ estimates of $44.49 billion, (according to FactSet).
Evernorth segment, which covers pharmacy services, benefits management, care solutions and data and analytics, experienced a + 7% rise in revenue on an adjusted basis.
The company boosted its outlook on adjusted earnings from operations to at least $22.90 a share, up 30 cents a share from prior guidance. (The forecast includes the impact of expected future share buybacks and dividends).